BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gustafsson J, Strom A, Warner M. Update on ERbeta. The Journal of Steroid Biochemistry and Molecular Biology 2019;191:105312. [DOI: 10.1016/j.jsbmb.2019.02.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Salahuddin A, Ghanem H, Omran GA, Helmy MW. Epigenetic restoration and activation of ERβ: an inspiring approach for treatment of triple-negative breast cancer. Med Oncol 2022;39:150. [PMID: 35843988 DOI: 10.1007/s12032-022-01765-1] [Reference Citation Analysis]
2 Brundin PMA, Landgren BM, Fjällström P, Shamekh MM, Gustafsson JÅ, Johansson AF, Nalvarte I. Expression of Sex Hormone Receptor and Immune Response Genes in Peripheral Blood Mononuclear Cells During the Menstrual Cycle. Front Endocrinol (Lausanne) 2021;12:721813. [PMID: 34630328 DOI: 10.3389/fendo.2021.721813] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Monaco A, Licitra F, Di Gisi M, Galasso G, Di Donato M, Giovannelli P, Migliaccio A, Castoria G. ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities. Endocrines 2021;2:356-65. [DOI: 10.3390/endocrines2030033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wu W, Warner M, Wang L, He WW, Zhao R, Guan X, Botero C, Huang B, Ion C, Coombes C, Gustafsson JA. Drivers and suppressors of triple-negative breast cancer. Proc Natl Acad Sci U S A 2021;118:e2104162118. [PMID: 34389675 DOI: 10.1073/pnas.2104162118] [Reference Citation Analysis]
5 Honma N, Matsuda Y, Mikami T. Carcinogenesis of Triple-Negative Breast Cancer and Sex Steroid Hormones. Cancers (Basel) 2021;13:2588. [PMID: 34070471 DOI: 10.3390/cancers13112588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ma HY, Chen S, Du Y. Estrogen and estrogen receptors in kidney diseases. Ren Fail 2021;43:619-42. [PMID: 33784950 DOI: 10.1080/0886022X.2021.1901739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Pinton G, Manzotti B, Balzano C, Moro L. Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative review. J Thorac Dis 2021;13:1851-63. [PMID: 33841973 DOI: 10.21037/jtd-20-2277] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Zhang L, Tian M, Lin J, Zhang J, Wang H, Li Z. Estrogen Receptor β1 Expression Patterns Have Different Effects on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors' Treatment Response in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma. Front Oncol 2020;10:603883. [PMID: 33585221 DOI: 10.3389/fonc.2020.603883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hattori Y, Ishii H, Higo S, Otsuka M, Kanaya M, Matsumoto K, Ozawa M, Ozawa H. Optimization of immunohistochemical detection of rat ESR2 proteins with well-validated monoclonal antibody PPZ0506. Mol Cell Endocrinol 2021;523:111145. [PMID: 33400952 DOI: 10.1016/j.mce.2020.111145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hess RA, Sharpe RM, Hinton BT. Estrogens and development of the rete testis, efferent ductules, epididymis and vas deferens. Differentiation 2021;118:41-71. [PMID: 33441255 DOI: 10.1016/j.diff.2020.11.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Yan S, Dey P, Ziegler Y, Jiao X, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS. Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer. Breast Cancer Res Treat 2021;185:281-92. [PMID: 33001337 DOI: 10.1007/s10549-020-05948-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
12 Hattori Y, Ishii H, Tahara S, Morita A, Ozawa H. Accurate assessment of estrogen receptor profiles in non-functioning pituitary adenomas using RT-digital PCR and immunohistochemistry. Life Sci 2020;260:118416. [PMID: 32926922 DOI: 10.1016/j.lfs.2020.118416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sellitto A, D'Agostino Y, Alexandrova E, Lamberti J, Pecoraro G, Memoli D, Rocco D, Coviello E, Giurato G, Nassa G, Tarallo R, Weisz A, Rizzo F. Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer. Cancers (Basel) 2020;12:E1477. [PMID: 32516978 DOI: 10.3390/cancers12061477] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
14 Lombardi APG, Vicente CM, Porto CS. Estrogen Receptors Promote Migration, Invasion and Colony Formation of the Androgen-Independent Prostate Cancer Cells PC-3 Through β-Catenin Pathway. Front Endocrinol (Lausanne) 2020;11:184. [PMID: 32328032 DOI: 10.3389/fendo.2020.00184] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
15 Warner M, Wu WF, Montanholi L, Nalvarte I, Antonson P, Gustafsson JA. Ventral prostate and mammary gland phenotype in mice with complete deletion of the ERβ gene. Proc Natl Acad Sci U S A 2020;117:4902-9. [PMID: 32075916 DOI: 10.1073/pnas.1920478117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
16 Di Zazzo E, Galasso G, Giovannelli P, Di Donato M, Bilancio A, Perillo B, Sinisi AA, Migliaccio A, Castoria G. Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer. Cancers (Basel) 2019;11:E1418. [PMID: 31548498 DOI: 10.3390/cancers11101418] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]